AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $211.77
-
Support level$181.43
-
Resistance levelN/A
-
Beta0.0
-
RSI (14-day)63.2
- ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- ABBV is one of this month's top performers with a return of 9.5 percent, beating 90 percent of stocks in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.0 percent for every 1% increase in the S&P-500.
- ABBV is one of this week's least volatile stocks in the S&P-100 with an estimated annualized standard deviation of 21.7%.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$154.79 | $216.66 | 93.2% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$184.58 | $191.00 | $206.81 | $212.15 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.9%
-
In the next month13.4%
-
In the next year48.0%
Period | Value |
---|---|
Historical (5 year) | 25.0% |
Last month | 22.0% |
Current estimate | 21.7% |
Next month forecast | 23.7% |